S&P 5007,765.36▼0.5% Nasdaq27,193.34▼1.2% Dow51,231.64▲0.1% Russell 2K2,794.13▲0.0% 10-Yr5.23%−5bp VIX15.41+0.33 WTI$91.10▲3.2% Gold$4,157.80▲0.4% EUR/USD1.122▼0.3% BTC$84,464▲1.8% Nikkei70,036▼0.9%
At close · Thu, Oct 8, 2026
Daily Market Updates.

Crypto

Home›Crypto›Bitcoin›OpenAI Buys Orchestra Bio to Put AI Agents in Charge o…

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Reported · Written up by our desk · Bitcoin

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.

← Newer storyWalmart takes aim at Amazon and Costco with new membership program ,…

More like this

CryptoObol Urges Immediate Charon Upgrade After CA Key Compromise
CryptoRailway Urges All Users to Rotate Secrets After Security Incident
CryptoWhy earning XRP yield through this wallet could actually cost you money
CryptoKen Griffin Says AI Is 'Almost Certainly' in a Bubble,And Compares GPUs to Airline Seats
CryptoeMudhra's Weak Certificate Keys Prompt Emergency Trust Updates

Sources

DecryptOpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.